Janicke F - Search Results

1

Model system for isolation of competent ovarian-carcinoma cells from fresh tumor-tissue by a magnetic separation technique (macs).

Harbeck N, Schwarze S, Schuren E, Yamamoto N, Moniwa N, Schmitt M, Dettmar P, Nathrath W, Janicke F, Hofler H, Graeff H. Harbeck N, et al. Among authors: janicke f. Int J Oncol. 1995 Jun;6(6):1249-54. doi: 10.3892/ijo.6.6.1249. Int J Oncol. 1995. PMID: 21556665

2

Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA).

Chucholowski N, Schmitt M, Goretzki L, Schüren E, Moniwa N, Weidle U, Kramer M, Wagner B, Jänicke F, Graeff H. Chucholowski N, et al. Among authors: janicke f. Biochem Soc Trans. 1992 Feb;20(1):208-16. doi: 10.1042/bst0200208. Biochem Soc Trans. 1992. PMID: 1321752 Review. No abstract available.

3

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.

Jänicke F, Hölscher M, Kuhn W, von Hugo R, Pache L, Siewert JR, Graeff H. Jänicke F, et al. Cancer. 1992 Oct 15;70(8):2129-36. doi: 10.1002/1097-0142(19921015)70:8<2129::aid-cncr2820700820>3.0.co;2-u. Cancer. 1992. PMID: 1394042

4

Tumor-associated urokinase-type plasminogen activator: biological and clinical significance.

Schmitt M, Jänicke F, Moniwa N, Chucholowski N, Pache L, Graeff H. Schmitt M, et al. Among authors: janicke f. Biol Chem Hoppe Seyler. 1992 Jul;373(7):611-22. doi: 10.1515/bchm3.1992.373.2.611. Biol Chem Hoppe Seyler. 1992. PMID: 1515091 Review.

5

Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.

Goretzki L, Schmitt M, Mann K, Calvete J, Chucholowski N, Kramer M, Günzler WA, Jänicke F, Graeff H. Goretzki L, et al. Among authors: janicke f. FEBS Lett. 1992 Feb 3;297(1-2):112-8. doi: 10.1016/0014-5793(92)80339-i. FEBS Lett. 1992. PMID: 1551416 Free article.

6

[Prognostic factors in breast cancer and their consequences for therapeutic decisions].

Graeff H, Jänicke F. Graeff H, et al. Among authors: janicke f. Chirurg. 1992 Jun;63(6):461-8. Chirurg. 1992. PMID: 1643982 Review. German. No abstract available.

7

Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.

Schmitt M, Chucholowski N, Busch E, Hellmann D, Wagner B, Goretzki L, Jänicke F, Günzler WA, Graeff H. Schmitt M, et al. Among authors: janicke f. Semin Thromb Hemost. 1991 Jul;17(3):291-302. doi: 10.1055/s-2007-1002623. Semin Thromb Hemost. 1991. PMID: 1724574

8

[Secondary surgical interventions in ovarian cancer].

Jänicke F, Kuhn W, Hölscher M, Graeff H. Jänicke F, et al. Gynakol Rundsch. 1991;31 Suppl 2:26-34. Gynakol Rundsch. 1991. PMID: 1790947 Review. German. No abstract available.

9

[Flow cytometry DNA analysis of pure cell nuclei from formalin fixed paraffin sections in primary breast cancer: correlation with other prognostic factors].

Harbeck N, Moniwa N, Busch E, Schmitt M, Jänicke F, Fellbaum C, Höfler H, Graeff H. Harbeck N, et al. Among authors: janicke f. Gynakol Rundsch. 1991;31 Suppl 2:299-302. Gynakol Rundsch. 1991. PMID: 1790958 German. No abstract available.

10

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer.

Jänicke F, Schmitt M, Graeff H. Jänicke F, et al. Semin Thromb Hemost. 1991 Jul;17(3):303-12. doi: 10.1055/s-2007-1002624. Semin Thromb Hemost. 1991. PMID: 1796300 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters